Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
NPJ Vaccines|February 9, 2024
Exploring the future adult vaccine landscape-crowded schedules and new dynamicsCharles H Jones, Matthew P Jenkins, B Adam Williams, et al.Molecular Pharmaceutics|October 8, 2013
Polymyxin B treatment improves bactofection efficacy and reduces cytotoxicityCharles H Jones, Snehal Rane, Emily Patt, et al.Biomaterials|May 6, 2015
Influence of molecular weight upon mannosylated bio-synthetic hybrids for targeted antigen presenting cell gene deliveryCharles H Jones, Akhila Gollakota, Mingfu Chen, et al.Iscience|March 24, 2025
Stakeholder perspective and sentiment in a rapidly growing United States adult vaccination environmentAnthony Hill, Ryan Arvin, Marie Beitelshees, et al.Biomaterials|December 3, 2014
Mannosylated poly(beta-amino esters) for targeted antigen presenting cell immune modulationCharles H Jones, Mingfu Chen, Anitha Ravikrishnan, et al.Iscience|September 15, 2025
Stakeholder readiness in the evolving adult vaccine marketMatthew P Jenkins, Anthony Hill, Antonietta F Forte, et al.PNAS Nexus|December 20, 2024
In silico prediction of pathogen's pandemic potential using the viral trait assessment for pandemics (ViTAP) modelCharles H Jones, Marie Beitelshees, B Adam Williams, et al.Molecular Pharmaceutics|April 8, 2015
Improved Escherichia coli Bactofection and Cytotoxicity by Heterologous Expression of Bacteriophage ΦX174 Lysis Gene ETai-Chun Chung, Charles H Jones, Akhila Gollakota, et al.Proceedings of the National Academy of Sciences of the United States of America|May 19, 2025
Framework to identify innovative sources of value creation from platform technologiesCharles H Jones, Marie Beitelshees, Andrew Hill, et al.FEMS Microbiology Letters|December 16, 2025
Genotypic and phenotypic comparison of Neisseria meningitidis carriage and invasive disease isolates contemporaneously collected in the NetherlandsCharles H Jones, Zhenghui Li, Li Hao, et al.Pageof 5